CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
Numbers of patients, length of follow-up keep growing with no visible downside (yet)
Source: medpagetoday.com
Stay updated with breaking news from John Gever. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Numbers of patients, length of follow-up keep growing with no visible downside (yet)
And it's on the pharmacy shelf now
Post-hoc analysis shows that body weight makes an important difference
Now the question is how to reconcile this study with others finding a benefit
Population-based study fails to confirm earlier findings